射频消融联合数字减影血管造影引导下无水乙醇硬化治疗头颈部高回流静脉畸形的临床效果  

Clinical effect of radiofrequency ablation combined with digital subtraction angiography-guided percutaneous ethanol injection sclerotherapy in the management of high-return flow venous malformation

作　　者：王兴[1] 孟箭[1] 张杰[1] 吴蕊含 辜建敏 邵翠玲[1] 

机构地区：[1]东南大学医学院附属徐州医院口腔科,221009

出　　处：《中华医学美学美容杂志》2016年第1期45-48,共4页Chinese Journal of Medical Aesthetics and Cosmetology

摘　　要：目的 探讨射频消融技术联合数字减影血管造影（DsA）引导下无水乙醇硬化治疗头颈部高回流静脉畸形的临床疗效。方法采用随机数字表法将41例头颈部高回流静脉畸形患者分为观察组（19例）和对照组（22例），观察组辅以射频消融治疗，两组均给予DSA引导下无水乙醇硬化治疗，对两组患者的近期疗效进行评价，并分析比较两组患者的治疗次数和不良反应。结果观察组有效率94．7％（18／19），显著优于对照组的81．8％（18／22）（P〈0．05）。对照组无水乙醇注射后出现3例面瘫，观察组无面神经损伤症状者。另外，观察组无水乙醇注射（1．84±0．83）次显著少于对照组的（2．55±0．96）次（P〈0．05）。结论射频消融技术能够显著提高头颈部高回流静脉畸形的疗效，减少无水乙醇注射次数，且安全性良好。Objective To investigate the clinical effect of radiofrequency ablation （RF） combined with digital subtraction angiography （DSA）-guided percutaneous ethanol injection sclerotherapy in the management of high-return flow venous malformation （VM）. Methods Forty-one patients, who were diagnosed as high-return flow VM with clinical and radiographic evidence, were divided into the observation group （n= 19） and the control group （n= 22） using a random number table. All highreturn flow VM patients received DSA-guided percutaneous ethanol injection sclerotherapy while the patients in observation group were given radiofrequency ablation. The clinical effect, treatment times and adverse effect of the two groups were analyzed. Results The effectiveness of the observation group was significantly higher than those of the control group [94.7% （18/19） vs 81.8%（18/22）]. The facial paralysis occurred in three patients （13. 6%） after ethanol injection in the control group, while the observation group had no facial nerve injury after treatment, The patients in observation group had significantly fewer numbers of ethanol injection. Conclusions RF can improve the efficacy of high-return flow VM and reduce the number of ethanol injection. The scheme is safe and effective.

关 键 词：射频消融术 静脉畸形 无水乙醇 综合序列治疗 

分 类 号：R543.6[医药卫生—心血管疾病]